Active	Status	Sponsor type	Region	Phase	Filter
3 Active 6 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Caritis, Steve N
NCT03831113: Pharmacologically-based Strategies for Opioid Substitution Therapy During Pregnancy	Terminated	2	13	US	Magnitude Group, magnitude, Frequency Group, frequency	Steve N. Caritis, MD, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)	Opiate Addiction, Pregnancy	12/22	12/22
NCT02863601: Impact of Pregnancy on Buprenorphine Pharmacokinetics and Pharmacodynamics	Completed	N/A	25	US		University of Pittsburgh	Opiate Addiction, Pregnancy	05/22	05/22
NCT04183452: 17-OHPC in Pregnancy: IM vs SC Routes	Terminated	N/A	24	US	17-Hydroxyprogesterone Caproate 250 mg IM Dose, 17-OHPC, 17-Hydroxyprogesterone Caproate 275 mg SC Dose	Steve N. Caritis, MD, AMAG Pharmaceuticals, Inc.	Preterm Birth	04/23	04/23
Cotroneo, Peggy
No trials found